Well that dispels any doubt about impact of FDA regulations for our US products FIN is produced to FDA standards so if anything should be good news not negative. There is absolutely no reason why we should be trading any where near this obscene market cap only that Management needs to address manipulation by doing roadshows getting new buy interest from institutions etc. through PR/IR, Roadshows etc
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.